Structure of the claudin-binding domain of Clostridium perfringens enterotoxin
- PMID: 17977833
- DOI: 10.1074/jbc.M708066200
Structure of the claudin-binding domain of Clostridium perfringens enterotoxin
Abstract
Clostridium perfringens enterotoxin is a common cause of food-borne and antibiotic-associated diarrhea. The toxin's receptors on intestinal epithelial cells include claudin-3 and -4, members of a large family of tight junction proteins. Toxin-induced cytolytic pore formation requires residues in the NH(2)-terminal half, whereas residues near the COOH terminus are required for binding to claudins. The claudin-binding COOH-terminal domain is not toxic and is currently under investigation as a potential drug absorption enhancer. Because claudin-4 is overexpressed on some human cancers, the toxin is also being investigated for targeting chemotherapy. Our aim was to solve the structure of the claudin-binding domain to advance its therapeutic applications. The structure of a 14-kDa fragment containing residues 194 to the native COOH terminus at position 319 was solved by x-ray diffraction to a resolution of 1.75A. The structure is a nine-strand beta sandwich with previously unappreciated similarity to the receptor-binding domains of several other toxins of spore-forming bacteria, including the collagen-binding domain of ColG from Clostridium histolyticum and the large Cry family of toxins (including Cry4Ba) of Bacillus thuringiensis. Correlations with previous studies suggest that the claudin-4 binding site is on a large surface loop between strands beta8 and beta9 or includes these strands. The sequence that was crystallized (residues 194-319) binds to purified human claudin-4 with a 1:1 stoichiometry and affinity in the submicromolar range similar to that observed for binding of native toxin to cells. Our results provide a structural framework to advance therapeutic applications of the toxin and suggest a common ancestor for several receptor-binding domains of bacterial toxins.
Similar articles
-
Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein.FEBS Lett. 2000 Jul 7;476(3):258-61. doi: 10.1016/s0014-5793(00)01744-0. FEBS Lett. 2000. PMID: 10913624
-
Structure of a C. perfringens enterotoxin mutant in complex with a modified Claudin-2 extracellular loop 2.J Mol Biol. 2014 Sep 9;426(18):3134-3147. doi: 10.1016/j.jmb.2014.07.001. Epub 2014 Jul 11. J Mol Biol. 2014. PMID: 25020226 Free PMC article.
-
Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5.Cell Mol Life Sci. 2015 Apr;72(7):1417-32. doi: 10.1007/s00018-014-1761-6. Epub 2014 Oct 24. Cell Mol Life Sci. 2015. PMID: 25342221 Free PMC article.
-
On the interaction of Clostridium perfringens enterotoxin with claudins.Toxins (Basel). 2010 Jun;2(6):1336-56. doi: 10.3390/toxins2061336. Epub 2010 Jun 8. Toxins (Basel). 2010. PMID: 22069641 Free PMC article. Review.
-
The interaction of Clostridium perfringens enterotoxin with receptor claudins.Anaerobe. 2016 Oct;41:18-26. doi: 10.1016/j.anaerobe.2016.04.011. Epub 2016 Apr 16. Anaerobe. 2016. PMID: 27090847 Free PMC article. Review.
Cited by
-
Structural Basis of Clostridium perfringens Enterotoxin Activation and Oligomerization by Trypsin.Toxins (Basel). 2023 Oct 31;15(11):637. doi: 10.3390/toxins15110637. Toxins (Basel). 2023. PMID: 37999500 Free PMC article.
-
Storming the gate: New approaches for targeting the dynamic tight junction for improved drug delivery.Adv Drug Deliv Rev. 2023 Aug;199:114905. doi: 10.1016/j.addr.2023.114905. Epub 2023 Jun 3. Adv Drug Deliv Rev. 2023. PMID: 37271282 Free PMC article. Review.
-
Disruption of Claudin-Made Tight Junction Barriers by Clostridium perfringens Enterotoxin: Insights from Structural Biology.Cells. 2022 Mar 5;11(5):903. doi: 10.3390/cells11050903. Cells. 2022. PMID: 35269525 Free PMC article. Review.
-
Tight Junction Modulating Bioprobes for Drug Delivery System to the Brain: A Review.Pharmaceutics. 2020 Dec 19;12(12):1236. doi: 10.3390/pharmaceutics12121236. Pharmaceutics. 2020. PMID: 33352631 Free PMC article. Review.
-
Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer.J Nucl Med. 2020 Dec;61(12):1756-1763. doi: 10.2967/jnumed.120.243113. Epub 2020 May 15. J Nucl Med. 2020. PMID: 32414951 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials